Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous coronary intervention complications and guide catheter size: bigger is not better.
Grossman PM, Gurm HS, McNamara R, Lalonde T, Changezi H, Share D, Smith DE, Chetcuti SJ, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Grossman PM, et al. Among authors: moscucci m. JACC Cardiovasc Interv. 2009 Jul;2(7):636-44. doi: 10.1016/j.jcin.2009.05.012. JACC Cardiovasc Interv. 2009. PMID: 19628187 Free article.
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention.
Gurm HS, Smith DE, Collins JS, Share D, Riba A, Carter AJ, LaLonde T, Kline-Rogers E, O'Donnell M, Changezi H, Zughaib M, Safian R, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Gurm HS, et al. Among authors: moscucci m. J Am Coll Cardiol. 2008 Feb 5;51(5):529-35. doi: 10.1016/j.jacc.2007.09.053. J Am Coll Cardiol. 2008. PMID: 18237680 Free article.
Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registry.
Kasapis C, Gurm HS, Chetcuti SJ, Munir K, Luciano A, Smith D, Aronow HD, Kassab EH, Knox MF, Moscucci M, Share D, Grossman PM. Kasapis C, et al. Among authors: moscucci m. Circ Cardiovasc Interv. 2010 Dec;3(6):593-601. doi: 10.1161/CIRCINTERVENTIONS.110.957381. Epub 2010 Nov 9. Circ Cardiovasc Interv. 2010. PMID: 21062999
Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.
Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M; BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry. Gurm HS, et al. Among authors: moscucci m. J Am Coll Cardiol. 2011 Aug 23;58(9):907-14. doi: 10.1016/j.jacc.2011.05.023. J Am Coll Cardiol. 2011. PMID: 21851878 Free article.
Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention.
Gurm HS, Smith DE, Berwanger O, Share D, Schreiber T, Moscucci M, Nallamothu BK; BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium). Gurm HS, et al. Among authors: moscucci m. JACC Cardiovasc Interv. 2012 Jan;5(1):98-104. doi: 10.1016/j.jcin.2011.09.019. JACC Cardiovasc Interv. 2012. PMID: 22230155 Free article.
162 results